CCS associates INC:1109683 [16-065720]

Ended Awarded Last action

Contract number
HHSN26100005
Awardee
Awarding agency
Obligated
$1,286,665

Award facts

Opportunity
  • RFQ11008804 Solicitation number
Contract value 100% obligated
$1,286,665.09 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00006 · To DE-obligate funds from FY2018 expiring lines in accordance with NIH oalm communication 23-18 -$0
Other Administrative Action P00005 -$0
Exercise an Option P00004 · Support for strategic planning activities for NCI's cssi (task 1) task order 05; option year 4 period of performance 09/15/2020 - 09/14/2021 $267,345
Exercise an Option P00003 · CCS associates INC:1109683, task order 05; option year 3; task 1- support for strategic planning activities for NCI's cssi period of performance 09/15/2019 -… $262,240
Exercise an Option 1 $252,328
Exercise an Option 2 · CCS associates INC:1109683 [16-065720] period of performance 09/15/2016 - 09/14/2018 $257,235
Original award $247,518

About this award

This $1,286,665.09 federal contract was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to CCS Associates, Inc., a woman-owned small business contract research organization. The contract is a delivery order and has a firm fixed price pricing type. CCS Associates will provide a range of services to support NCI's cancer prevention efforts, including information management, regulatory services, and technical support. The contract is not a set-aside award.

CCS Associates has secured numerous federal contracts and grants from NIH institutes, including the National Institute on Drug Abuse, National Institute of Neurological Disorders and Stroke, National Center for Advancing Translational Sciences, and the Food and Drug Administration. The company holds several significant indefinite delivery vehicles (IDVs) with NIH to provide comprehensive research support services across infectious, immunologic, and allergic diseases, as well as regulatory and drug development assistance for rare disease and addiction treatments.

Quick answers

Who was awarded contract HHSN26100005?

HHSN26100005 was awarded to CCS Associates, Inc. by National Cancer Institute (National Institutes of Health) on September 15, 2016.

How much is contract HHSN26100005 worth?

The government has obligated $1,286,665 on HHSN26100005.

Is contract HHSN26100005 an order under another contract?

Yes. HHSN26100005 is a delivery order under HHSN261201100016I, an indefinite delivery contract.

Was contract HHSN26100005 competed?

The extent of competition for HHSN26100005 was competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award